Company intelligence / Profile preview

NeXtal Biotechnologies

Holland, Ohio, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

NeXtal Biotechnologies is a provider of tools for protein crystallization in structural biology research. It specializes in protein crystallization tools, including screens like DWBlock, Tubes Suites, Cations Suite, Classics Suite, and µplates. The company focuses on consumables simplifying protein sample preparation for crystallographic analysis, supporting research in drug discovery by enabling 3D protein structure determination. It has no clinical pipeline or therapeutic programs.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on NeXtal Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeXtal Biotechnologies.

Explore the full profile